BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29215762)

  • 1. Risk of amphetamine use disorder and mortality among incident users of prescribed stimulant medications in the Veterans Administration.
    Westover AN; Nakonezny PA; Halm EA; Adinoff B
    Addiction; 2018 May; 113(5):857-867. PubMed ID: 29215762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration.
    Bohnert KM; Ilgen MA; Louzon S; McCarthy JF; Katz IR
    Addiction; 2017 Jul; 112(7):1193-1201. PubMed ID: 28301070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study.
    McCabe SE; Veliz P; Wilens TE; Schulenberg JE
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):226-233.e4. PubMed ID: 28219488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
    Moran LV; Ongur D; Hsu J; Castro VM; Perlis RH; Schneeweiss S
    N Engl J Med; 2019 Mar; 380(12):1128-1138. PubMed ID: 30893533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
    Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of dementia in older female US veterans with alcohol use disorder.
    Bahorik A; Bobrow K; Hoang T; Yaffe K
    Addiction; 2021 Aug; 116(8):2049-2055. PubMed ID: 33449402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
    Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
    JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment.
    Seal KH; Cohen G; Waldrop A; Cohen BE; Maguen S; Ren L
    Drug Alcohol Depend; 2011 Jul; 116(1-3):93-101. PubMed ID: 21277712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system.
    Cassidy TA; McNaughton EC; Varughese S; Russo L; Zulueta M; Butler SF
    J Atten Disord; 2015 Apr; 19(4):275-83. PubMed ID: 23900405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant medication use in college students: comparison of appropriate users, misusers, and nonusers.
    Hartung CM; Canu WH; Cleveland CS; Lefler EK; Mignogna MJ; Fedele DA; Correia CJ; Leffingwell TR; Clapp JD
    Psychol Addict Behav; 2013 Sep; 27(3):832-40. PubMed ID: 24059834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019.
    Board AR; Guy G; Jones CM; Hoots B
    Drug Alcohol Depend; 2020 Dec; 217():108297. PubMed ID: 32961454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.
    Compton WM; Han B; Blanco C; Johnson K; Jones CM
    Am J Psychiatry; 2018 Aug; 175(8):741-755. PubMed ID: 29656665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.
    Poulin C
    Addiction; 2007 May; 102(5):740-51. PubMed ID: 17506151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Trends in Stimulant Usage.
    Safer DJ
    J Atten Disord; 2016 Jun; 20(6):471-7. PubMed ID: 26486603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.